Google News, page-6

Whilst 1,111 patients will probably be enrolled fairly quickly, I think they may enrol many more before finalising results for the FDA submission. Its important that there are enough pneumonia etc cases included rather than too high a percentage of common URTI infections etc. that is unless they are targetting and selecting patients with more severe symptoms. Do'nt know but I hope we get a trial update that may give clues soon.
Fox